SYNOPSIS
The influence of calcium on fibrinolysis in vitro has been studied. In the absence of inhibitors, fibrinolytic activity is enhanced by calcium. In whole blood the inhibitory effect of calcium on fibrinolysis can be explained by its effect on the inhibitors present. Anti-activator is dependent on the presence of calcium for its formation, although calcium has no further influence on its action. Antiplasmin activity is enhanced by the presence of calcium.
There have been many conflicting reports on the effect of calcium on the fibrinolytic system. Fearnley and Tweed (1953) first observed that ionic calcium caused some inhibition of diluted plasma clot lysis. This was later confirmed by Sherry, Lindemeyer, Fletcher, and Alkjaersig (1959) , and Thomas (1958) ieported the inhibition of streptokinase-induced clot lysis by calcium. Ratnoff (1952) , however, noted an accelerating effect of calcium on the euglobulin lysis time, and this was confirmed by Kowalski, Kopec, and Niewiaroswki (1959) .
Explanations of the inhibitory effect of calcium on plasma clot lysis were given by Bidwell (1953) , who suggested that the type of fibrin influences the rate of fibrinolysis, and by Bickford and Sokolow (1961) , who suggested that the urea-insoluble fibrin formed in the presence of calcium is less susceptible to fibrinolysis than the urea-soluble form. Medart (1958) proposed that calcium disturbs the equilibrium between two forms of fibrinogen, the one susceptible, the other inhibitory, to fibrinolysis. None of these workers took into account the conflicting results reported by Ratnoff (1952) in the euglobulin lysis time.
Ratnoff concluded that the acceleration of euglobulin clot lysis was due to the effect of calcium on the activation of plasminogen, and not on the action of plasmin. Although this fits in with the subsequent findings of Kowalski, Latallo, and Niewiarowski (1956) should be more fully investigated, in order to discover whether calcium accelerates or inhibits fibrinolysis, and, if the latter, whether it acts directly on plasmin or indirectly through the inhibitors. The inhibitory components of the fibrinolytic system considered in this paper are the combined effect of the antiplasmins (Norman, 1960) and the antiactivator effect described by Flute (1960) . In plasma the inactive precursor plasminogen is acted upon by blood activator to form the fibrinolytic enzyme plasmin. This activation of plasminogen to plasmin is inhibited by anti-activator, which is formed rapidly on incubation of blood in glass (Flute, 1960) . The proteolytic action of plasmin on fibrin is inhibited by the antiplasmins which are present in circulating blood (Norman, 1960) . The effect of calcium on the fibrinolytic system as a whole is measured in plasma. To separate the enzymes and their inhibitors use is made of the euglobulin precipitation method. The euglobulin fraction prepared at 4°C. immediately after collection of blood is used as a source of activator, plasminogen, and plasmin, free from inhibitors. The effect of calcium on anti-activator is tested in the euglobulin fraction prepared from incubated plasma or serum. This fraction will contain anti-activator but no antiplasmins. The role of calcium in the formation of anti-activator is studied by comparing euglobulin fractions of serum incubated both in the presence and absence of calcium. The combined influence of anti-activator and antiplasmin is measured in incubated serum. In this way the effect of calcium on the components of the fibrinolytic system has been studied. DECALCIFYING AGENTS These are (1) 10 % dipotassium ethylene diamine tetra-acetate (E.D.T.A.) (0-1 ml./10 ml. blood); (2) 3-8 % trisodium citrate (1 ml./10 ml. blood); and (3) 0-1 M ammonium oxalate (1 ml./10 ml. blood).
The E.D.T.A. interfered to some extent with the subsequent clotting procedures, and, as citrate was found to be suitable for the removal of calcium in these experiments, this was used in the majority of the tests.
FIBRINOGEN Solution of bovine fibrinogen (bovine plasma fraction I, Armour Pharmaceutical Co.) containing 0 5 g. in 100 ml. buffer. THROMBIN Solution of bovine thrombin (Thrombin Reagent, Leo Pharmaceutical Products) containing 50 N.J.H. units/ml. saline. This has been found to be free from significant contamination by components of the fibrinolytic system. STREPTOKINASE Streptokinase-streptodornase Varidase (Lederle Laboratories). BUFFERS Veronal buffer, pH 7 4, ionic strength 0-154, was prepared from the following formula: sodium diethyl barbiturate, 11-745 g., sodium chloride 14-67 g., 0-1 N hydrochloric acid 430 ml., distilled water to 2 litres.
Sodium borate solution, pH 9 0, was prepared from sodium chloride 9 g., sodium borate 1 g., distilled water to 1 litre.
METHODS

SEPARATION OF THE ENZYMES FROM THEIR INHIBITORS
Inhibitor-free euglobulin fraction was prepared by the following method. Venous blood was collected into a plastic syringe which had been cooled to 4°C. and placed in a precooled plastic tube containing anticoagulant and immediately centrifuged at 1,710 g (3,250 r.p.m.) for 10 minutes at 4°C. The platelet-poor plasma was transferred to 18 times its volume of ice-cold distilled water and the pH adjusted to 5 3 by the addition of 1 % acetic acid (usually one-fifth of the plasma volume). This was allowed to stand at 4°C. for 30 minutes, then centrifuged at 1,710 g (3,250 r.p.m.) for 10 minutes at 4°C. and the supernatant discarded. The resulting euglobulin precipitate was free from significant antiplasmin activity; meticulous observance of the cold handling technique and use of plastic apparatus prevented the formation of antiactivator.
Antiplasmin-free euglobulin fraction was prepared from plasma or serum which had been incubated in a glass container at 370C. for 30 minutes to allow formation of anti-activator. Once formed, this is precipitated with the euglobulin fraction (Flute, 1960) .
MEASUREMENT OF FIBRINOLYTIC ACTIVITY The fibrin plate (Astrup and Mullertz, 1952) was prepared using bovine fibrinogen (0-5 g. Armour plasma fraction 1/100 ml. buffer) and thrombin, modified by the incorporation of The heated fibrin plate (Lassen, 1953) was prepared using bovine fibrinogen and thrombin, again modified by the inclusion of calcium or sodium chloride in the plate.
The euglobulin lysis time was determined as follows:-The euglobulin precipitate derived from 0 5 ml. plasma is dissolved in 0-5 ml. buffer. To 0 4 ml. of this solution 0 5 ml. 0-01 M CaCl2, 0025 M CaCl2 or 0-12 M NaCl is added, and the mixture clotted with 0-1 ml. thrombin. The time taken for complete dissolution of the clot at 37°C. is called the euglobulin lysis time.
RESULTS
EFFECT OF CALCIUM ON FIBRINOLYSIS AS MEASURED IN
PLASMA Citrated platelet-poor plasma was activated by adding streptokinase, 100 units/ml. plasma, and aliquots were applied immediately to unheated fibrin plates, containing calcium or sodium chloride. As shown in Table I , there is significantly less lysis in the presence of calcium. It must be borne in mind (Table III) . These results also indicate that calcium enhances fibrinolysis in the absence of inhibitors. Euglobulin lysis times were then set up, using 0 4 ml. inhibitor-free euglobulin fraction and varying amounts of antiplasmin-free euglobulin fraction in a clot of volume 1 1 ml. Calcium or sodium chloride was added before clotting with thrombin. As seen in Table V , the addition of antiplasmin-free euglobulin fraction prolongs the euglobulin lysis time, due to the presence of anti-activator. Calcium, however, does not increase this inhibition. Thus anti-activator, once formed, is not influenced by calcium, and the inhibitory action of calcium on whole blood lysis cannot be explained by its effect on anti-activator.
EFFECT OF CALCIUM ON DEVELOPMENT OF ANTI-ACTIVATOR in vitro There remains the effect of calcium on the formation of anti-activator, and Flute (1962) has suggested that calcium is indeed necessary for its formation. Anti-activator is not identifiable as such in circulating blood, but is formed after incubation in contact with glass (Flute, 1960) . In order to test the effect of calcium on its formation, 3 ml. platelet-poor E.D.T.A. plasma (0 1 ml. 100% E.D.T.A. per 100 ml. plasma) and 3 ml.
native plasma were clotted with 01 ml. thrombin (500 N.I.H. units/ml.), incubated in glass for 30 minutes at 37°C. The clots were then removed, E.D.T.A. added to the serum containing none, and euglobulin precipitates prepared from each. The anti-activator activity of each of these fractions was tested by adding varying amounts to 0-4 ml. inhibitor-free euglobulin fraction, and carrying 
DISCUSSION
The inhibitory effect of calcium on lysis in plasma (Sherry et al., 1959) , and its accelerating effect on euglobulin clot lysis (Ratnoff, 1952) 
It is well known that metallic ions acting as cofactors can play an important role in enzymatic reactions. It seems that the fibrinolytic system offers no exception: in the absence of inhibitors, the lysis of fibrin proceeds more rapidly when calcium is present. It has not been determined whether calcium accelerates the proteolytic activity of plasmin itself, or influences the activation of plasminogen to plasmin by activator. Ratnoff (1952) believed that activator is affected directly, but could not demonstrate this using streptokinase or chloroform. The elucidation of this problem is made difficult by the fact that any test ultimately depends on the proteolytic activity of plasmin, and thus it is hard to distinguish between activator and plasminogen on the one hand and plasmin on the other.
In the light of the results using the euglobulin fraction, it was thought that the inhibitory effect of calcium in clot lysis could not be due merely to the different type of fibrin formed in the presence of calcium as suggested by Bickford and Sokolow (1961). They pointed out that the sulphydryl-bonded fibrin formed in the presence of calcium is insoluble in urea, and put forward the hypothesis that this sulphydryl-bonded fibrin might also be more resistant to the fibrinolytic enzymes. This difference in solubility of fibrin in urea is dependent on both calcium and the fibrin stabilizing factor (Laki and L6ramnd, 1948) and it may be that this factor plays some part in making the clot more resistant to the fibrinolytic enzymes. The 
